THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, Ben-Ari Z, Heneghan MA, Harrison SA, Minuk GY, Schattenberg J, Moreno C, Vierling JM, Vincent C, Bowlus CL, Lurie Y, Muratori L, Niro G, Hirschfield G, Post AB, Zeuzen S, Welzel T, Ch'Ng C, Levy C, Miller MH, Collier JD, Corless L, Dieterich DT, Kremer A, Papatheodoridis GV, Romeo DP, Silveira MG, Bernstein DE, Naftaly-Cohen M, Floreani A, Borg B, Carey EJ, Hollywood C, Maliakkal BJ, Marzioni M, Rabinovitz M, Rupp C, Sheridan DA, Stanca CM, Swain MG, Veitsman E, Ntourakis SP, Wiesel P (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 777A-779A

Conference Proceedings Title: HEPATOLOGY

Event location: Boston, MA

Authors with CRIS profile

Involved external institutions

University of Thessaly / Πανεπιστήμιο Θεσσαλίας Greece (GR) University of Rochester (UR) United States (USA) (US) Swansea Bay University Health Board United Kingdom (GB) National and Kapodistrian University of Athens Greece (GR) Casa Sollievo della Sofferenza Italy (IT) Houston Texas Medical Center United States (USA) (US) Université libre de Bruxelles (ULB) / Free University of Brussels Belgium (BE) Rabin Medical Center / מרכז רפואי רבין‎‎ Israel (IL) King's College Hospital (KCH) United Kingdom (GB) Université de Montréal Canada (CA) Mount Sinai Hospital (MSH) Canada (CA) Hull and East Yorkshire Hospitals NHS Trust United Kingdom (GB) University of Manitoba Canada (CA) University of Bologna / Università di Bologna Italy (IT) Universitätsklinikum Frankfurt am Main (KGU) Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz Germany (DE) Yale University United States (USA) (US) University of California Davis (UCDAVIS) United States (USA) (US) University of Oxford United Kingdom (GB) Shaare Zedek Medical Center / מרכז רפואי שערי צדק‎‎, Israel (IL) University Health Network (UHN) Canada (CA) Dayton Gastroenterology, Inc. United States (USA) (US) University of Padua / Universita degli Studi di Padova Italy (IT) Mayo Clinic in Arizona United States (USA) (US) Universitätsklinikum Heidelberg Germany (DE) NYU Langone Hospitals United States (USA) (US) Hospital Universitario Virgen de la Victoria Spain (ES) Tel Aviv University Israel (IL) Università Politecnica delle Marche (UNIVPM) / Marche Polytechnic University Italy (IT) Universiteit Gent (UGent) / Ghent University Belgium (BE) Gloucestershire Hospitals United Kingdom (GB) Pinnacle Clinical Research United States (USA) (US) University of Pittsburgh Medical Center (UPMC) United States (USA) (US) Chaim Sheba Medical Center at Tel HaShomer / המרכז הרפואי עש חיים שיבא – תל השומר‎‎ Israel (IL) Katholieke Universiteit Leuven (KUL) / Catholic University of Leuven Belgium (BE) University of Tennessee (UTK) United States (USA) (US) University of Calgary Canada (CA) University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB Italy (IT) University of Plymouth United Kingdom (GB) Northwell Health United States (USA) (US) University of Miami United States (USA) (US) University Hospitals of Cleveland / Case Western Reserve University Hospital United States (USA) (US)

How to cite

APA:

Huang, J.C., Invernizzi, P., Dalekos, G.N., Nevens, F., Van Vlierberghe, H., Zigmond, E.,... Wiesel, P. (2019). THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS. In HEPATOLOGY (pp. 777A-779A). Boston, MA, US: HOBOKEN: WILEY.

MLA:

Huang, Jonathan C., et al. "THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS." Proceedings of the Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA HOBOKEN: WILEY, 2019. 777A-779A.

BibTeX: Download